Related Experiment Video
Updated: Jun 25, 2025
07:18
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
5.8K
Post-Transcriptional HIV-1 Latency: A Promising Target for Therapy?
Mie Kobayashi-Ishihara1, Yasuko Tsunetsugu-Yokota2
1Department of Molecular Biology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Viruses
|May 25, 2024
Summary
Human Immunodeficiency Virus type 1 (HIV-1) latency is a major obstacle to cure. This review highlights post-transcriptional regulation as a key factor in HIV-1 latency and a promising therapeutic target.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) latency is a critical barrier to achieving a cure for HIV-1 infection.
- Understanding the complex interplay of host and viral factors in HIV-1 latency is essential for therapeutic development.
Purpose of the Study:
- To review recent advances in understanding post-transcriptional regulation in HIV-1 latency.
- To explore therapeutic targets within the post-transcriptional control of HIV-1 infections.
- To identify host factors that inhibit HIV-1 at the post-transcriptional level.
Main Methods:
- Literature review of recent research on HIV-1 post-transcriptional regulation.
- Analysis of host factors influencing viral latency.
- Discussion of potential therapeutic strategies targeting post-transcriptional mechanisms.
Main Results:
- Post-transcriptional regulation plays a crucial role in establishing and maintaining HIV-1 latency.
- Therapeutic targets for post-transcriptional regulation are less explored but show significant potential.
- Specific host factors have been identified that restrict HIV-1 replication post-transcriptionally.
Conclusions:
- Targeting post-transcriptional regulation offers a novel strategy for HIV-1 cure research.
- Further investigation into host-viral interactions at the post-transcriptional level is warranted.
- Developing therapies focused on post-transcriptional control could overcome latency challenges.
